{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T23:43:56Z","timestamp":1750463036687},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2004,1,1]],"date-time":"2004-01-01T00:00:00Z","timestamp":1072915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2004,1]]},"DOI":"10.1007\/s11910-004-0014-8","type":"journal-article","created":{"date-parts":[[2007,5,25]],"date-time":"2007-05-25T13:39:47Z","timestamp":1180100387000},"page":"62-67","source":"Crossref","is-referenced-by-count":17,"title":["Neuromuscular complications in HIV"],"prefix":"10.1007","volume":"4","author":[{"given":"Susama","family":"Verma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Micsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lydia","family":"Estanislao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"14_CR1","first-page":"189","volume-title":"AIDS and the Nervous System","author":"D Simpson","year":"1997","unstructured":"Simpson D, Tagliati M: Neuromuscular syndromes in human immunodeficiency virus disease. In AIDS and the Nervous System. Editd by Berger JL. Philadelphia: Lippincott-Raven; 1997:189\u2013221."},{"key":"14_CR2","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1212\/WNL.38.5.794","volume":"38","author":"DR Cornblath","year":"1988","unstructured":"Cornblath DR, McArthur JC: Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology 1988, 38:794\u2013796.","journal-title":"Neurology"},{"key":"14_CR3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ana.410230510","volume":"23","author":"SM Monte de la","year":"1988","unstructured":"de la Monte SM, Gabuzda DH, Ho DD, et al.: Peripheral neuropathy in the acquired immunodeficiency syndrome. Ann Neurol 1988, 23:485\u2013492.","journal-title":"Ann Neurol"},{"key":"14_CR4","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s11910-001-0058-y","volume":"1","author":"D Williams","year":"2001","unstructured":"Williams D, Geraci A, Simpson D: AIDS and AIDS-treatment neuropathies. Curr Neurol Neurosci Rep 2001, 1:533\u2013538.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"14_CR5","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2165\/00003495-200059060-00005","volume":"59","author":"EA Wulff","year":"2000","unstructured":"Wulff EA, Wang AK, Simpson DM: HIV-associated peripheral neuropathy: epidemiology, pathophysiology and treatment. Drugs 2000, 59:1251\u20131260.","journal-title":"Drugs"},{"key":"14_CR6","first-page":"23","volume":"8","author":"E Wulff","year":"1998","unstructured":"Wulff E, Simpson D: HIV-associated neuropathy: recent advances in management. HIV Adv Res Ther 1998, 8:23\u201329.","journal-title":"HIV Adv Res Ther"},{"key":"14_CR7","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/archneur.58.10.1561","volume":"58","author":"F Brinley","year":"2001","unstructured":"Brinley F, Pardo C, Verma A: Human immunodeficiency virus and the peripheral nervous system workshop. Arch Neurol 2001, 58:1561\u20131566.","journal-title":"Arch Neurol"},{"key":"14_CR8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1002\/ana.410340616","volume":"34","author":"S Apostolski","year":"1993","unstructured":"Apostolski S, McAlarney T, Quattrini A, et al.: The gp120 glycoprotein of human immunodeficiency virus type 1 binds to sensory ganglion neurons. Ann Neurol 1993, 34:855\u2013863.","journal-title":"Ann Neurol"},{"key":"14_CR9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0165-5728(01)00288-0","volume":"116","author":"U Herzberg","year":"2001","unstructured":"Herzberg U, Sagen J: Peripheral nerve exposure to HIV viral envelope protein gp120 incudes neuropathic pain and spinal gliosis. J Neuroimmunol 2001, 116:29\u201339.","journal-title":"J Neuroimmunol"},{"issue":"suppl 2","key":"14_CR10","first-page":"A232","volume":"43","author":"J Griffin","year":"1993","unstructured":"Griffin J, Grfiffin D: mRNA fingerprinting of cytokines and growth factors: a new means of characterizing nerve biopsies. Neurology 1993, 43(suppl 2):A232.","journal-title":"Neurology"},{"key":"14_CR11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0960-5428(06)80258-5","volume":"4","author":"S Wesselingh","year":"1994","unstructured":"Wesselingh S, Glass J, McArthur J, et al.: Cytokine dysregulation in HIV-associated neurological disease. Adv Neuroimmunol 1994, 4:199\u2013206.","journal-title":"Adv Neuroimmunol"},{"key":"14_CR12","first-page":"379","volume":"9","author":"WR Tyor","year":"1995","unstructured":"Tyor WR, Wesselingh SL, Griffin JW, et al.: Unifying hypothesis for the pathogenesis of HIV-associated dementia complex, vacuolar myelopathy, and sensory neuropathy. J AIDS Hum Retrovirol 1995, 9:379\u2013388.","journal-title":"J AIDS Hum Retrovirol"},{"key":"14_CR13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0022-510X(95)00317-U","volume":"136","author":"I Nagano","year":"1996","unstructured":"Nagano I, Shapshak P, Yoshioka M, et al.: Increased NADPHdiaphorase reactivity and cytokine expression in dorsal root ganglia in acquired immunodeficiency syndrome. J Neurol Sci 1996, 136:117\u2013128.","journal-title":"J Neurol Sci"},{"key":"14_CR14","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/BF00296507","volume":"90","author":"N Rizzuto","year":"1995","unstructured":"Rizzuto N, Cavallaro T, Monaco S, et al.: Role of HIV in the pathogenesis of distal symmetrical peripheral neuropathy. Acta Neuropathol 1995, 90:244\u2013250.","journal-title":"Acta Neuropathol"},{"key":"14_CR15","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1212\/WNL.44.6.1120","volume":"44","author":"M Yoshioka","year":"1994","unstructured":"Yoshioka M, Shapshak P, Srivastava AK, et al.: Expression of HIV-1 and interleukin-6 in lumbosacral dorsal root ganglia of patients with AIDS. Neurology 1994, 44:1120\u20131130.","journal-title":"Neurology"},{"key":"14_CR16","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1097\/00002030-200211080-00002","volume":"16","author":"S Keswani","year":"2002","unstructured":"Keswani S, Pardo C, Cherry C, et al.: HIV-associated sensory neuropathies. AIDS 2002, 16:2105\u20132117.","journal-title":"AIDS"},{"key":"14_CR17","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1046\/j.1440-1711.1998.00778.x","volume":"76","author":"S Petratos","year":"1998","unstructured":"Petratos S, Turnbull V, Papadopoulos R, et al.: Antibodies against peripheral myelin glycolipids in people with HIV infection. Immunol Cell Biol 1998, 76:535\u2013541.","journal-title":"Immunol Cell Biol"},{"key":"14_CR18","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1001\/archneur.1991.00530150082023","volume":"48","author":"K Keilburtz","year":"1991","unstructured":"Keilburtz K: Abnormal vitamin B12 metabolism in human immunodeficiency virus infection: association with neurologic dysfunction. Arch Neurol 1991, 48:312\u2013315.","journal-title":"Arch Neurol"},{"key":"14_CR19","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1001\/archneur.1988.00520330023005","volume":"45","author":"YT So","year":"1988","unstructured":"So YT, Holtzman DM, Abrams DI, Olney RK: Peripheral neuropathy associated with acquired immunodeficiency syndrome. Prevalence and clinical features from a populationbased survey. Arch Neurol 1988, 45:945\u2013948.","journal-title":"Arch Neurol"},{"key":"14_CR20","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1212\/WNL.38.5.794","volume":"38","author":"D Cornblath","year":"1988","unstructured":"Cornblath D, McArthur J: Predominantly sensory neuropathy in patients with AIDS and AIDS-related complex. Neurology 1988, 38:794\u2013796.","journal-title":"Neurology"},{"key":"14_CR21","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1212\/WNL.44.10.1892","volume":"44","author":"H Bacellar","year":"1994","unstructured":"Bacellar H, Munoz A, Miller EN, et al.: Temporal trends in the incidence of HIV-1-related neurologic diseases: Multicenter AIDS Cohort Study, 1985\u20131992. Neurology 1994, 44:1892\u20131900.","journal-title":"Neurology"},{"key":"14_CR22","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1212\/WNL.58.12.1764","volume":"58","author":"G Schifitto","year":"2002","unstructured":"Schifitto G, McDermott M, McArthur J, et al.: Incidence of and risk factors for HIV-associated distal sensory polyneuropathy. Neurology 2002, 58:1764\u20131768. A prospective study to analyze risk factors and predictors of HIV DSP in addition to d-drugs, CD4 lymphocyte count, and viral load.","journal-title":"Neurology"},{"key":"14_CR23","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/ana.410240604","volume":"24","author":"V Mah","year":"1988","unstructured":"Mah V, Vartavarian LM, Akers MA, Vinters HV: Abnormalities of peripheral nerve in patients with human immunodeficiency virus infection. Ann Neurol 1988, 24:713\u2013717.","journal-title":"Ann Neurol"},{"key":"14_CR24","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/00019052-200306000-00022","volume":"16","author":"C Luciano","year":"2003","unstructured":"Luciano C, Pardo J, McArthur J: Recent developments in HIV neuropathies. Curr Opin Neurol 2003, 16:403\u2013409. This paper reviews the most recent developments in HIV neuropathy. Skin punch biopsy, as a reliable tool for evaluating the nerve fiber density and monitoring DSP, is described in this article.","journal-title":"Curr Opin Neurol"},{"key":"14_CR25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1001\/archneur.55.1.41","volume":"55","author":"P Heseltine","year":"1998","unstructured":"Heseltine P, Goodkin K, Atkinson J, et al.: A randomized doubleblind placebo-controlled trial of Peptide T for HIV-associated cognitive impairment. Arch Neurol 1998, 55:41\u201351.","journal-title":"Arch Neurol"},{"key":"14_CR26","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1212\/WNL.47.5.1254","volume":"47","author":"D Simpson","year":"1996","unstructured":"Simpson D, Dorfman D, Olney R, et al.: Peptide T in the treatment of painful distal neuropathy associated with AIDS; Results of a placebo-controlled trial. The Peptide T Neuropathy Study Group. Neurology 1996, 47:1254\u20131259.","journal-title":"Neurology"},{"key":"14_CR27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00002030-199509020-00006","volume":"9","author":"D Simpson","year":"1995","unstructured":"Simpson D, Tagliati M: Nucleoside analogue-associated peripheral neuropathy in human immunodeficiency virus infection. J AIDS 1995, 9:153\u2013161.","journal-title":"J AIDS"},{"key":"14_CR28","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1212\/WNL.46.4.999","volume":"46","author":"A Blum","year":"1996","unstructured":"Blum A, Dal Pan G, Feinberg J, et al.: Low dose zalcitabinerelated toxic neuropathy: frequency, natural history, and risk factors. Neurology 1996, 46:999\u20131003.","journal-title":"Neurology"},{"key":"14_CR29","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1529-8027.2001.006001014.x","volume":"16","author":"M Dalakas","year":"2001","unstructured":"Dalakas M: Peripheral neuropathy and antiretroviral drugs. J Periph Nervous System 2001, 16:14\u201320. An article on neuropathy associated with toxic antiretrovirals in HIV patients.","journal-title":"J Periph Nervous System"},{"issue":"suppl 1","key":"14_CR30","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1093\/clinids\/16.Supplement_1.S63","volume":"16","author":"IM Pike","year":"1993","unstructured":"Pike IM, Nicaise C: The didanosine Expanded Access Program: safety analysis. Clin Infect Dis 1993, 16(suppl 1):S63-S68.","journal-title":"Clin Infect Dis"},{"key":"14_CR31","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1177\/106002809202601101","volume":"2","author":"R Rathburn","year":"1992","unstructured":"Rathburn R, Martin EI: Didanosine therapy in patients intolerant of or failing zidovudine therapy. Ann Pharmacother 1992, 2:1347\u20131351.","journal-title":"Ann Pharmacother"},{"key":"14_CR32","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2165\/00002018-199819060-00005","volume":"19","author":"GJ Moyle","year":"1998","unstructured":"Moyle GJ, Sadler M: Peripheral neuropathy with nucleoside antiretrovirals: risk factors, incidence and management. Drug Safety 1998, 19:481\u2013494.","journal-title":"Drug Safety"},{"key":"14_CR33","first-page":"169","volume":"10","author":"C Fichtenbaum","year":"1995","unstructured":"Fichtenbaum C, Clifford D, Powderly W: Risk factors for dideoxynucleoside-induced toxic neuropathy in patients with the human immunodeficiency virus infection. J AIDS Hum Retrovir 1995, 10:169\u2013174.","journal-title":"J AIDS Hum Retrovir"},{"key":"14_CR34","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1016\/S0021-9258(18)80156-9","volume":"264","author":"C Chen","year":"1989","unstructured":"Chen C, Cheng Y: Delayed cytotoxicity and selective loss of mitochondrial DNA in cells treated with the anti-human immunodeficiency virus compound 2\u20323\u2032-dideoxycytidine. J Biol Chem 1989, 264:11934\u201311937.","journal-title":"J Biol Chem"},{"key":"14_CR35","first-page":"63","volume":"66","author":"TD Anderson","year":"1992","unstructured":"Anderson TD, Davidovich A, Arceo R, et al.: Peripheral neuropathy induced by 2\u2032,3\u2032-dideoxycytidine. A rabbit model of 2\u2032,3\u2032-dideoxycytidine neurotoxicity. Lab Invest 1992, 66:63\u201374.","journal-title":"Lab Invest"},{"key":"14_CR36","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1016\/0006-2952(91)90672-R","volume":"42","author":"S Kailbaugh","year":"1991","unstructured":"Kailbaugh S, Prusoff W, Simson M: The PC 12 cell as a model for studies of the mechanism of induction of peripheral neuropathy by anti-HIV 1 dideoxynucleoside analogs. Biochem Pharmacol 1991, 42:R5-R8.","journal-title":"Biochem Pharmacol"},{"key":"14_CR37","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1136\/sti.77.3.158","volume":"77","author":"A White","year":"2001","unstructured":"White A: Mitochondrial toxicity and HIV therapy. Sex Transm Infect 2001, 77:158\u2013173.","journal-title":"Sex Transm Infect"},{"key":"14_CR38","first-page":"486","volume":"2","author":"J Arezzo","year":"2000","unstructured":"Arezzo J: Dideoxycytidine and other nucleoside analogs. Exp Clin Neurotoxicol 2000, 2:486\u2013489.","journal-title":"Exp Clin Neurotoxicol"},{"key":"14_CR39","unstructured":"Brew B, Tisch S, Law M: Lactate concentrations distinguish between nucleoside neuropathy and HIV distal symmetrical sensory polyneuropathy (abstract 9). Presented at 8th Conference on Retroviruses and Opportunistic Infections. Chicago, IL, 2001."},{"key":"14_CR40","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1086\/313912","volume":"31","author":"J Lonergan","year":"2000","unstructured":"Lonergan J, Behling C, Pfander H, et al.: Hyperlactatemia and hepatic abnormalities in 10 human immunodeficiency virus infected patients receiving nucleoside analogue combination regimens. Clin Infect Dis 2000, 31:162\u2013166.","journal-title":"Clin Infect Dis"},{"key":"14_CR41","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.410240114","volume":"24","author":"DM Simpson","year":"1988","unstructured":"Simpson DM, Bender AN: Human immunodeficiency virusassociated myopathy: analysis of 11 patients. Ann Neurol 1988, 24:79\u201384.","journal-title":"Ann Neurol"},{"key":"14_CR42","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1212\/WNL.43.5.971","volume":"43","author":"DM Simpson","year":"1993","unstructured":"Simpson DM, Citak KA, Godfrey E, et al.: Myopathies associated with human immunodeficiency virus and zidovudine: can their effects be distinguished? [see comments]. Neurology 1993, 43:971\u2013976.","journal-title":"Neurology"},{"key":"14_CR43","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1212\/WNL.41.10.1603","volume":"41","author":"RG Miller","year":"1991","unstructured":"Miller RG, Carson PJ, Moussavi RS, et al.: Fatigue and myalgia in AIDS patients. Neurology 1991, 41:1603\u20131607.","journal-title":"Neurology"},{"key":"14_CR44","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1002\/(SICI)1097-4598(199703)20:3<382::AID-MUS22>3.0.CO;2-1","volume":"20","author":"DM Simpson","year":"1997","unstructured":"Simpson DM, Slasor P, Dafni U, et al.: Analysis of myopathy in a placebo-controlled zidovudine trial. Muscle Nerve 1997, 20:382\u2013385.","journal-title":"Muscle Nerve"},{"key":"14_CR45","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/ana.410360511","volume":"36","author":"D Chad","year":"1994","unstructured":"Chad D, Smith T, Blumenfield D, et al.: HIV-associated myopathy: Immunocytochemical identification of an HIV antigen (gp41) in muscle macrophages. Ann Neurol 1994, 36:752\u2013758.","journal-title":"Ann Neurol"},{"key":"14_CR46","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJM199004193221602","volume":"322","author":"MC Dalakas","year":"1990","unstructured":"Dalakas MC, Illa I, Pezeshkpour GH, et al.: Mitochondrial myopathy caused by long-term zidovudine therapy. N Engl J Med 1990, 322:1098\u20131105.","journal-title":"N Engl J Med"},{"key":"14_CR47","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1097\/00002030-200012010-00012","volume":"14","author":"Y Gerard","year":"2000","unstructured":"Gerard Y, Maulin L, Yazdanpanah Y, et al.: Symptomatic hyperlactatemia: an emerging complication of antiretroviral therapy. AIDS 2000, 14:2723\u20132730.","journal-title":"AIDS"},{"key":"14_CR48","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1086\/339041","volume":"34","author":"V Falco","year":"2002","unstructured":"Falco V, Rodriguez D, Ribera E, et al.: Severe nucleoside-associated lactic acidosis in HIV-infected patients: report of 12 cases and review of the literature. Clin Infect Dis 2002, 34:838\u2013846.","journal-title":"Clin Infect Dis"},{"key":"14_CR49","first-page":"151","volume":"4","author":"H May","year":"2000","unstructured":"May H, Laut F, Palmisano J, et al.: Lactic acidosis and antiretroviral therapy: a case report and literature review. Braz J Infect Dis 2000, 4:151\u2013155.","journal-title":"Braz J Infect Dis"},{"key":"14_CR50","unstructured":"Marcus K, Truffa M, Boxwell D, Toerner J: Recently identified adverse events secondary to NRTI therapy in HIV-infected individuals: cases from the FDA\u2019s adverse event reporting system (AERS). Presented at 9th Conference on Retroviruses and Opportunistic Infections. Seattle, WA, 2002."},{"key":"14_CR51","unstructured":"Galera C, Redondo C, Pozo G: Symptomatic hyperlactatemia and lactic acidosis syndrome in HIV patients treated with nucleoside analogue reverse transcriptase inhibitors. Presented at 1st Conference on HIV Pathogenesis and Treatment. Buenos Aires, Argentina, 2001."},{"key":"14_CR52","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1212\/WNL.53.6.1365","volume":"53","author":"A Verma","year":"1999","unstructured":"Verma A, Roland M, Jayaweera D, Kett D: Fulminant neuropathy and lactic acidosis associated with nucleoside analog therapy. Neurology 1999, 53:1365\u20131369.","journal-title":"Neurology"},{"key":"14_CR53","doi-asserted-by":"crossref","first-page":"192","DOI":"10.7326\/0003-4819-133-3-200008010-00010","volume":"133","author":"KD Miller","year":"2000","unstructured":"Miller KD, Cameron M, Wood LV, et al.: Lactic acidosis and hepatic steatosis associated with use of stavudine: report of four cases. Ann Intern Med 2000, 133:192\u2013196.","journal-title":"Ann Intern Med"},{"key":"14_CR54","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1086\/313594","volume":"30","author":"MH Mokrzycki","year":"2000","unstructured":"Mokrzycki MH, Harris C, May H, et al.: Lactic acidosis associated with stavudine administration: a report of five cases. Clin Infect Dis 2000, 30:198\u2013200.","journal-title":"Clin Infect Dis"},{"key":"14_CR55","doi-asserted-by":"crossref","unstructured":"Simpson D, Estanislao L, Marcus K, et al.: HIV-Associated neuromuscular weakness syndrome. Presented at 10th Conference on Retrovirus and Opportunistic Infections. Boston, MA; 2003.","DOI":"10.1097\/01.aids.0000131309.70451.fe"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-004-0014-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11910-004-0014-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-004-0014-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,14]],"date-time":"2021-08-14T07:05:08Z","timestamp":1628924708000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11910-004-0014-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2004,1]]}},"alternative-id":["14"],"URL":"https:\/\/doi.org\/10.1007\/s11910-004-0014-8","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,1]]}}}